e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Anti-infective treatment and resistance in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Macrolide-resistant
Mycoplasma pneumoniae
in adolescents with community-acquired pneumonia
N. Miyashita, Y. Kawai, M. Kubo, K. Ouchi, N. Okimoto (Okayama, Japan)
Source:
Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Session:
Anti-infective treatment and resistance in respiratory infections
Session type:
Poster Discussion
Number:
4368
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Miyashita, Y. Kawai, M. Kubo, K. Ouchi, N. Okimoto (Okayama, Japan). Macrolide-resistant
Mycoplasma pneumoniae
in adolescents with community-acquired pneumonia. Eur Respir J 2012; 40: Suppl. 56, 4368
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Community-acquired pneumonia in children
Source: Annual Congress 2012 - PG15 Common respiratory infections in childhood: current guidelines and controversies
Year: 2012
Mixed community-acquired pneumonia in hospitalised patients
Source: Eur Respir J 2006; 27: 795-800
Year: 2006
Particularities of community-acquired pneumonia in the elderly
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007
Bacteraemia in outpatients with community-acquired pneumonia
Source: Eur Respir J 2016; 47: 654-657
Year: 2016
Ethyology of community-acquired pneumonia in servicemen at the age of 18–21
Source: Eur Respir J 2006; 28: Suppl. 50, 736s
Year: 2006
Legionella
pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Peculiarities of community-acquired pneumonia in tobacco-smoking patients
Source: Annual Congress 2009 - Tobacco: from smoke to disease
Year: 2009
Etiology of community-acquired pneumoniae in young adults
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Epidemiology of community-acquired pneumonia and nosocomial pneumonia
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Community-acquired pneumonia in younger patients is an entity on its own
Source: Eur Respir J 2012; 39: 1156-1161
Year: 2012
The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Community-acquired pneumonia in outpatients: aetiology and outcomes},
Source: Eur Respir J 2012; 40: 931-938
Year: 2012
Clostridium difficile
infection following community-acquired pneumonia
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011
Bacterial infections and community-acquired pneumonia in children
Source: Annual Congress 2011 - Paediatric Year in Review
Year: 2011
Etiology of community-acquired pneumonia (CAP) in young hospital patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002
Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Etiological spectrum of hospitalized community-acquired pneumonia
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007
Preventing community-acquired pneumonia
Source: International Congress 2019 – Respiratory infections: prevention is better than cure
Year: 2019
Community-acquired pneumonia
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept